HAS-BLED Bleeding Risk Calculator
HAS-BLED bleeding risk calculator. Estimates 1-year major bleeding risk on oral anticoagulation. The counterweight to CHA₂DS₂-VASc. Educational only.
HAS-BLED Bleeding Risk Calculator
Please tick the acknowledgement above before calculating.
How to use the HAS-BLED calculator
Tick each factor present
HAS-BLED awards one point for each of nine bleeding risk factors. Be honest and thorough — under-counting hides genuine risk, over-counting exaggerates it.
Use the strict definitions
"Hypertension" here means uncontrolled (systolic > 160). Abnormal renal and liver function are separate points, as are drugs and alcohol — so the same patient can score up to 2 from each pair.
Acknowledge, then read the band
Tick the acknowledgement to reveal the score, risk band, and an approximate major-bleed rate. A score of 0–2 is generally low risk; 3 or more is high.
Treat it as a prompt, not a veto
A high HAS-BLED is not a reason to stop anticoagulation. It identifies modifiable risks to fix and patients to monitor closely — the bleeding counterweight to the CHA₂DS₂-VASc stroke score. Decisions are made with a physician.
HAS-BLED — the bleeding counterweight to CHA₂DS₂-VASc
Two scores, one decision
Deciding whether a patient with atrial fibrillation should take an anticoagulant is a balance: the drug cuts stroke risk but raises bleeding risk. The stroke side is quantified by the CHA₂DS₂-VASc score; the bleeding side by HAS-BLED, published by Pisters and colleagues in 2010. The acronym spells out nine one-point factors — Hypertension (uncontrolled), Abnormal renal function, Abnormal liver function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly (over 65), Drugs that promote bleeding (antiplatelets, NSAIDs), and Alcohol excess. Renal and liver function are scored separately, as are drugs and alcohol, so the maximum is nine. Higher totals predict a higher one-year risk of major bleeding, rising from roughly one bleed per hundred patient-years at a score of zero to around twelve at a score of five.
The crucial clinical insight is what the score is not for. A high HAS-BLED was never meant to be a reason to withhold anticoagulation — doing so would expose the patient to the very strokes the drug prevents. Instead it does two useful things: it flags the modifiable risk factors worth correcting before and during treatment (control the blood pressure, reduce alcohol, stop unnecessary antiplatelets or NSAIDs, stabilise a wandering INR), and it identifies the patients who need closer follow-up. In most people, a high stroke risk and a high bleeding risk coexist, and the net benefit of anticoagulation still favours treatment.
"A high HAS-BLED isn't a stop sign — it's a to-do list. It names the bleeding risks you can fix and the patients you should watch, not the ones you should leave unprotected from stroke."
Reading it alongside the stroke score
HAS-BLED is most useful read next to CHA₂DS₂-VASc rather than alone. A patient with a high stroke score and a low bleeding score is a clear candidate for anticoagulation; a patient with high scores on both still usually benefits, but warrants attention to the correctable factors and perhaps a safer agent or device. Direct oral anticoagulants generally cause less serious bleeding than warfarin, which is one reason the "labile INR" factor — a warfarin-specific problem — has become less relevant in the DOAC era. None of this is a calculation a patient should act on alone: the score informs a shared decision with a cardiologist or GP who weighs the whole clinical picture, including frailty, falls risk, and patient preference. Used as intended — as a structured prompt rather than a gate — HAS-BLED has made anticoagulation safer for millions of people with atrial fibrillation worldwide.
10 Facts About HAS-BLED
Published 2010 by Pisters et al in Chest.
Nine one-point factors; maximum score 9.
0–2 = low bleeding risk; ≥3 = high.
It estimates 1-year major bleeding risk on anticoagulation.
It's the counterweight to the CHA₂DS₂-VASc stroke score.
A high score is not a reason to withhold anticoagulation.
It highlights modifiable risks: BP, alcohol, interacting drugs.
Renal and liver function score separately (up to 2).
"Labile INR" is warfarin-specific — less relevant with DOACs.
Used in ESC and other guidelines for bleeding-risk review.
Frequently asked questions
Hypertension (uncontrolled), Abnormal renal/liver function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly (over 65), Drugs (antiplatelets/NSAIDs) and Alcohol excess. Renal and liver, and drugs and alcohol, are scored separately, so the maximum is 9 points. Each factor present adds one point.
A HAS-BLED score of 0–2 is generally considered low-to-moderate bleeding risk, and 3 or more is high. In the original cohort the estimated major-bleed rate rose from about 1 per 100 patient-years at score 0 to roughly 12 at score 5. A "high" score signals a need to correct modifiable risks and review the patient closely, not to stop anticoagulation.
No — this is the most important point about the score. A high HAS-BLED is not a reason to withhold anticoagulation, because doing so leaves you exposed to the strokes the drug prevents. It identifies bleeding risks you can fix (blood pressure, alcohol, unnecessary antiplatelets or NSAIDs) and flags you for closer monitoring. Most people with high stroke risk and high bleeding risk still benefit from anticoagulation overall.
They are the two halves of the same decision. CHA₂DS₂-VASc estimates stroke risk (the reason to anticoagulate); HAS-BLED estimates bleeding risk (the cost). You read them together: high stroke risk plus low bleeding risk is a clear case for treatment; high on both still usually favours treatment, but with attention to correctable bleeding factors and closer follow-up.
In the original definition, abnormal renal function means chronic dialysis, kidney transplant, or a serum creatinine of 200 µmol/L (about 2.26 mg/dL) or higher. Abnormal liver function means chronic liver disease such as cirrhosis, or biochemical evidence of significant derangement (for example bilirubin more than twice the upper limit with transaminases more than three times). Each scores one point independently.
Less so. Labile INR — unstable or out-of-range INR with time-in-therapeutic-range below about 60% — is a problem specific to warfarin, which needs INR monitoring. Direct oral anticoagulants (DOACs) don't use the INR, so this factor doesn't apply to them. For a patient on a DOAC, that point is effectively zero, and the remaining factors still inform bleeding-risk review.
The "drugs" point covers concurrent medicines that increase bleeding risk, chiefly antiplatelet agents (aspirin, clopidogrel) and non-steroidal anti-inflammatory drugs (NSAIDs). Combining these with an anticoagulant multiplies bleeding risk, so this is one of the most modifiable factors — reviewing whether the antiplatelet or NSAID is truly needed can lower the score and the real-world risk.
HAS-BLED was developed and validated for bleeding risk in atrial fibrillation patients on oral anticoagulation, and that is where it is best supported. Clinicians sometimes use it informally to think about bleeding risk in other anticoagulation settings, but its quantitative estimates were derived from the AF population. For any other context, it should be treated as a rough guide, not a validated number.
You can use it to understand your bleeding-risk profile and to have a more informed conversation with your doctor, but the anticoagulation decision is a clinical one. It depends on your stroke risk, your full medical history, the specific drug, falls risk, and your own preferences. Never start or stop a blood thinner based on a calculator — use the score as a discussion aid.
No. The factors you tick are processed entirely in your browser. Nothing is transmitted to a server, stored, or shared, and no account is required. You can close the page knowing none of the information was recorded by RECATOOLS.
Related News
You may be interested in these recent stories from our newsroom.
No related news yet for this tool. Our editorial team publishes new pieces every week.
Browse all news →75 more free tools
Calculators, converters, security tools — no signup.